News about Drug Discovery & Development

Takara Bio Europe Rolls Out New NGS Profiling System and Chemistries

The Shasta Total RNA-Seq Kit is the first high-throughput single-cell total RNA profiling kit to offer full gene body coverage of up to 100,000 cells per run.

Drug Discovery & Development | 27/09/2024 | By Aishwarya |  395

Heron Therapeutics Gets FDA Approval for ZYNRELEF VAN

The VAN will replace the current vented vial spike and has the potential to simplify aseptic preparation, while also significantly reducing ZYNRELEF's withdrawal time down to between twenty and forty-five seconds.

Drug Discovery & Development | 26/09/2024 | By Aishwarya |  577

Lupin and Takeda to Commercialize Vonoprazan in India

Under the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India.

Drug Discovery & Development | 19/09/2024 | By Aishwarya |  810

MinervaX Partners with Wacker Biotech for Prophylactic Vaccine

MinervaX has joined forces with Wacker Biotech to manufacture MinervaX's active protein ingredients of its GBS vaccine.

Drug Discovery & Development | 18/09/2024 | By Aishwarya |  445

Somite Therapeutics Receives FDA Orphan Drug and RPDD Designations for SMT-M01

Somite Therapeutics' SMT-M01 program leverages the company's proprietary AlphaStem AI platform to develop a novel cell replacement therapy for DMD.

Drug Discovery & Development | 17/09/2024 | By Aishwarya |  729

C2 PHARMA Rolls Outs Naphazoline Hydrochloride

Naphazoline HCL is effective in alleviating red eyes and nasal congestion, making it suitable for both prescription and over-the-counter products.

Drug Discovery & Development | 16/09/2024 | By Aishwarya |  651

GC Cell Signs Licensing Deal with PT Bifarma Adiluhung for Immuncell-LC

Bifarma is recognized for operating Indonesia's first GMP-certified cell therapy production facility and possesses a comprehensive sales and marketing infrastructure focused on oncology, specializing in a cold chain distribution network that spans across Indonesia.

Drug Discovery & Development | 11/09/2024 | By Aishwarya |  529

Seegene Unveils New mpox RUO PCR Assays for Clade 1

Seegene Inc. has announced to launch a new type of research-use-only (RUO) PCR assay to address the spread of the monkeypox virus variant, Clade Ib, which is currently prevalent in Africa.

Drug Discovery & Development | 10/09/2024 | By Aishwarya |  142

Sun Pharma and Moebius Medical Receive FTD for MM-II for Treatment of Osteoarthritis Knee Pain

Sun Pharma and Moebius Medical have announced that the US Food and Drug Administration (FDA) has granted Fast Track designation (FTD) to MM-II (Large Liposomes of DPPC and DMPC) for the treatment of osteoarthritis knee pain.

Drug Discovery & Development | 07/09/2024 | By Aishwarya |  321

Lupin Unveils Mirabegron Extended-Release Tablets in US

Mirabegron Extended-Release Tablets, 50 mg is a generic equivalent of Myrbetriq Extended-Release Tablets, 50 mg of Astellas Pharma Global Development, Inc.

Drug Discovery & Development | 06/09/2024 | By Aishwarya |  455